Submit Manuscript  

Article Details


Ion-Responsive Drug Delivery Systems

[ Vol. 19 , Issue. 3 ]

Author(s):

Takayuki Yoshida*, Kohsuke Shakushiro and Kazuhiro Sako   Pages 225 - 238 ( 14 )

Abstract:


Background: Some kinds of cations and anions are contained in body fluids such as blood, interstitial fluid, gastrointestinal juice, and tears at relatively high concentration. Ionresponsive drug delivery is available to design the unique dosage formulations which provide optimized drug therapy with effective, safe and convenient dosing of drugs.

Objective: The objective of the present review was to collect, summarize, and categorize recent research findings on ion-responsive drug delivery systems.

Results: Ions in body fluid/formulations caused structural changes of polymers/molecules contained in the formulations, allow formulations exhibit functions. The polymers/molecules responding to ions were ion-exchange resins/fibers, anionic or cationic polymers, polymers exhibiting transition at lower critical solution temperature, self-assemble supramolecular systems, peptides, and metalorganic frameworks. The functions of ion-responsive drug delivery systems were categorized to controlled drug release, site-specific drug release, in situ gelation, prolonged retention at the target sites, and enhancement of drug permeation. Administration of the formulations via oral, ophthalmic, transdermal, and nasal routes has showed significant advantages in the recent literatures.

Conclusion: Many kinds of drug delivery systems responding to ions have been reported recently for several administration routes. Improvement and advancement of these systems can maximize drugs potential and contribute to patients in the world.

Keywords:

Ion-responsive drug delivery system, ion-exchange complex, lower critical solution temperature, controlled drug release, salting-out effect, taste-masking, in situ gelation, ophthalmic prolonged retention.

Affiliation:

Evolving Medical Solutions, Astellas Pharma Inc., Tsukuba, Evolving Medical Solutions, Astellas Pharma Inc., Tsukuba, Astellas Ireland Co., Limited, Dublin

Graphical Abstract:



Read Full-Text article